Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer

被引:0
作者
A Lugli
G Iezzi
I Hostettler
M G Muraro
V Mele
L Tornillo
V Carafa
G Spagnoli
L Terracciano
I Zlobec
机构
[1] Institute of Pathology,
[2] University of Basel,undefined
[3] Institute for Surgical Research and Hospital Management,undefined
[4] University of Basel,undefined
来源
British Journal of Cancer | 2010年 / 103卷
关键词
colorectal cancer; cancer stem cell; CD44; CD166; CD133; EpCAM;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:382 / 390
页数:8
相关论文
共 282 条
  • [1] Albini A(2007)The chemoinvasion assay: a method to assess tumor and endothelial cell invasion and its modulation Nat Protoc 2 504-511
  • [2] Benelli R(2005)Invasion and metastasis in colorectal cancer: epithelial-mesenchymal transition, mesenchymal-epithelial transition, stem cells and beta-catenin Cells Tissues Organs 179 56-65
  • [3] Brabletz T(2005)Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression Nat Rev Cancer 5 744-749
  • [4] Hlubek F(2009)Cancer stem cell markers CD133 and CD24 correlate with invasiveness and differentiation in colorectal adenocarcinoma World J Gastroenterol 15 2258-2264
  • [5] Spaderna S(1998)CD44V6 expression in human colorectal carcinoma Hum Pathol 29 627-635
  • [6] Schmalhofer O(2007)Cancer stem cells: models and concepts Annu Rev Med 58 267-284
  • [7] Hiendlmeyer E(2007)Phenotypic characterization of human colorectal cancer stem cells Proc Natl Acad Sci USA 104 10158-10163
  • [8] Jung A(2005)Tumour stem cells and drug resistance Nat Rev Cancer 5 275-284
  • [9] Kirchner T(2000)Ep-CAM overexpression in breast cancer as a predictor of survival Lancet 356 1981-1982
  • [10] Brabletz T(2007)Mammary stem cell number as a determinate of breast cancer risk Breast Cancer Res 9 109-232